SOURCE: ISNR

International Society for Neurofeedback and Research www.isnr.org

June 16, 2010 10:39 ET

The Journal of Neurotherapy Announces Neurofeedback to Be an Efficacious and Specific Modality for the Treatment of ADHD

This Position Paper Was Adopted by the International Society for Neurofeedback and Research

SAN RAFAEL, CA--(Marketwire - June 16, 2010) -  The Journal of Neurotherapy announces the publication of "A Position Paper on Neurofeedback for the Treatment of ADHD," in which the authors demonstrate that neurofeedback is a safe and efficacious treatment intervention for AD/HD, meeting a rating level of 5: Efficacious and Specific. The issue 14(2) of the journal is available online HERE.

The authors, Leslie Sherlin, PhD, Martijn Arns, MSc, Joel Lubar, PhD and Estate Sokhadze, PhD, reviewed over 40 studies which support the claim of level 5 efficacy and made recommendations for treatment and future study. These studies utilized different neurofeedback modalities and compared to different control groups, including medication. The neurofeedback modalities of theta/beta ratio and slow cortical potential training were represented most frequently. Most of these studies looked at impulse control, attention and hyperactivity measures. Impulse control and attention issues seem to be best remediated with neurofeedback training.

The International Society for Neurofeedback and Research (ISNR) (visit www.isnr.org) is pleased with these findings and hopes that they help in further promoting the neurofeedback modality to the medical and psychological communities and also encourage third party payers to consider neurofeedback as a viable modality for reimbursement.

Neurofeedback uses monitoring devices to provide moment-to-moment brain wave information back to the client. This self-regulation modality is non-invasive and may be a good alternative to medication. Research demonstrates that neurofeedback is also an effective intervention for Epilepsy. Ongoing research is investigating the effectiveness of neurofeedback for other disorders such as Autism, headaches, insomnia, anxiety, substance abuse, TBI and other pain disorders, and is promising.

About the International Society for Neurofeedback and Research: The ISNR (www.isnr.org) is a member organization whose mission is to promote excellence in clinical practice, educational applications, and research in applied neuroscience in order to better understand and enhance brain function.

The ISNR Research Foundation is comprised of a Board of Directors whose mission is to accomplish the necessary research to demonstrate that neurofeedback is or is not effective in particular disorders.

Contact Information

  • Contact:
    Cynthia Kerson, PhD
    ISNR
    Phone (415) 485-1344
    Fax (415) 485-1348

    1925 Francisco Blvd. E. #12
    San Rafael, CA 94901
    www.isnr.org
    Email Contact